Back

Interaction of gut microbiota-derived metabolites with inflammatory markers and cellular rejection in advanced heart failure patients treated with heart transplantation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: from basic mechanisms to long-term care Heart Transplantation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Kamila Florek

Institute of Heart Diseases, Wroclaw (Poland)

5 More presentations in this session

Presentation thumbnail
Changes in myocardial inflammation and viral infection in adults with inflammatory cardiomyopathy following long-term left ventricular assist device
Doctor M. Ruiz Cano (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
Prognosis in elderly patients hospitalized for heart failure with cognitive impairment
Doctor M. Iguchi (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Follow-up of left-ventricular assist device patients with telemonitoring: a national retrospective multicentric study on the Satelia LVAD web application
Doctor S. Nisse-Durgeat (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Primary and specialist palliative care for patients with advanced heart failure: a survey of healthcare provision practices by office-based physicians in Germany
Mr M. Blum (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Exploring the clinical and mechanistic impacts of the nitroxyl donors on heart failure management: a meta-analysis of hemodynamics effects and safety
Mr V. Ho (Debrecen, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: from basic mechanisms to long-term care

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The role of gut microbiota and short-chain fatty acids in patients with advanced heart failure undergoing orthotopic heart transplantation
thumbnail
Congress Presentation
Circulating metabolites in patients with chronic heart failure are related to increased lipid utilisation but not to gut microbiota alterations
thumbnail
Congress Presentation
The gut-microbiome derived phenylacetylglutamine predicts adverse events in patients with acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources